Cargando…
CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure
Increasing numbers of individuals have access to cannabinoid-based products containing various amounts of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Exposure to specific cannabinoids likely influences outcomes; however, current methods for quantifying cannabis exp...
Autores principales: | Lambros, Ashley M., Sagar, Kelly A., Dahlgren, M. Kathryn, Kosereisoglu, Deniz, El-Abboud, Celine, Smith, Rosemary T., Gruber, Staci A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090150/ https://www.ncbi.nlm.nih.gov/pubmed/37041309 http://dx.doi.org/10.1038/s41598-023-32671-9 |
Ejemplares similares
-
A survey of medical cannabis use during perimenopause and postmenopause
por: Dahlgren, M. Kathryn, et al.
Publicado: (2022) -
Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial
por: Dahlgren, Mary Kathryn, et al.
Publicado: (2022) -
Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment
por: Dahlgren, Mary Kathryn, et al.
Publicado: (2022) -
Made from concentrate? A national web survey assessing dab use in the United States
por: Sagar, Kelly A., et al.
Publicado: (2018) -
Urinary Tetrahydrocannabinol After 4 Weeks of a Full-Spectrum,
High-Cannabidiol Treatment in an Open-label Clinical Trial
por: Dahlgren, M. Kathryn, et al.
Publicado: (2020)